NYLIM
AVEO

New York Life Investment Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

New York Life Investment Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-508,822
Closed -$7.61M – 1464
2022
Q4 		$7.61M Buy
+508,822
New +$7.04M 0.09% 239

New York Life Investment Management's AVEO Position: Q1 2023 in Review

New York Life Investment Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 508,822 shares — an estimated $7.61M sold.

New York Life Investment Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $7.61M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • New York Life Investment Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • New York Life Investment Management sold 508,822 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $7.61M.
  • New York Life Investment Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • New York Life Investment Management's AVEO Pharmaceuticals, Inc. position peaked at $7.61M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on New York Life Investment Management's 13F filing for Q1 2023, filed 8 May 2023.